Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al . (2009)

By White Larry  

Molecular Imaging and Biology, Vol. 14, Iss. 4, 2012-08 ,pp. : 397-398

Springer Publishing Company

Access to resources Recommend Favorite

Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma

By Fougère Christian   Hundt Walter   Bröckel Nicole   Pfluger Thomas   Haug Alexander   Scher Bernhard   Hacker Marcus   Hahn Klaus   Reiser Maximilan   Tiling Reinhold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 12, 2006-12 ,pp. : 1417-1425

Springer Publishing Company

Access to resources Recommend Favorite

FDG-PET/CT in re-staging of patients with lymphoma

By Freudenberg L.   Antoch G.   Schütt P.   Beyer T.   Jentzen W.   Müller S.   Görges R.   Nowrousian M.   Bockisch A.   Debatin J.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 3, 2004-03 ,pp. : 325-329

Springer Publishing Company

Access to resources Recommend Favorite

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT

By Wever W.   Ceyssens S.   Mortelmans L.   Stroobants S.   Marchal G.   Bogaert J.   Verschakelen J.  

European Radiology, Vol. 17, Iss. 1, 2007-01 ,pp. : 23-32

Springer Publishing Company

Access to resources Recommend Favorite

¹¹C-Acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment

By Lin Chieh   Ho Chi-Lai   Ng Shu-Hang   Wang Po-Nan   Huang Yenlin   Lin Yu-Chun   Tang Tzung-Chih   Tsai Shu-Fan   Rahmouni Alain   Yen Tzu-Chen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 41-49

Springer Publishing Company

Access to resources Recommend Favorite